Siiri I. Salomaa

Siiri I. Salomaa

Auto-generated profile, based on publicly available information

Siiri I. Salomaa

Wellcome – MRC Stem Cell Institute, University of Cambridge, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge CB2 0AW, UK

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Current Biology
Verified
Journal Article
Closed access
SSSiiri I. Salomaa
Siiri I. Salomaa
MMMitro Miihkinen
Mitro Miihkinen
EKElena Kremneva
Elena Kremneva
IPIlkka Paatero
Ilkka Paatero
JLJohanna Lilja
Johanna Lilja
JIJohanna Ivaska
Johanna Ivaska

17 October 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EPEmilia Peuhu
Emilia Peuhu
SSSiiri I Salomaa
Siiri I Salomaa
NFNicola De Franceschi
Nicola De Franceschi
CPChristopher S Potter
Christopher S Potter
JSJohn P Sundberg
John P Sundberg
JPJeroen Pouwels
Jeroen Pouwels
SHARPIN (Shank-Associated RH Domain-Interacting Protein) is a component of the linear ubiquitin chain assembly complex (LUBAC), which enhances TNF-induced NF-κB activity. SHARPIN-deficient (Sharpincpdm/cpdm) mice display multi-organ inflammation and chronic proliferative dermatitis (cpdm) due to TNF-induced keratinocyte apoptosis. In cells, SHARPIN also inhibits integrins independently of LUBAC, but it has remained enigmatic whether elevated integrin activity levels in the dermis of Sharpincpdm/cpdm mice is due to increased integrin activity or is secondary to inflammation. In addition, the functional contribution of increased integrin activation to the Sharpincpdm/cpdm phenotype has not been investigated. Here, we find increased integrin activity in keratinocytes from Tnfr1-/- Sharpincpdm/cpdm double knockout mice, which do not display chronic inflammation or proliferative dermatitis, thus suggesting that SHARPIN indeed acts as an integrin inhibitor in vivo. In addition, we present evidence for a functional contribution of integrin activity to the Sharpincpdm/cpdm skin phenotype. Treatment with an integrin beta 1 function blocking antibody reduced epidermal hyperproliferation and epidermal thickness in Sharpincpdm/cpdm mice. Our data indicate that, while TNF-induced cell death triggers the chronic inflammation and proliferative dermatitis, absence of SHARPIN-dependent integrin inhibition exacerbates the epidermal hyperproliferation in Sharpincpdm/cpdm mice.

15 September 2017 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
MKMeraj H. Khan
Meraj H. Khan
SSSiiri I. Salomaa
Siiri I. Salomaa
GJGuillaume Jacquemet
Guillaume Jacquemet
UBUmar Butt
Umar Butt
MMMitro Miihkinen
Mitro Miihkinen
JPJeroen Pouwels
Jeroen Pouwels
Sharpin, a multifunctional adaptor protein, regulates several signalling pathways. For example, Sharpin enhances signal-induced NF-κB signalling as part of the linear ubiquitin assembly complex (LUBAC) and inhibits integrins, the T cell receptor, caspase 1 and PTEN. However, despite recent insights into Sharpin and LUBAC function, a systematic approach to identify the signalling pathways regulated by Sharpin has not been reported. Here, we present the first ‘Sharpin interactome’, which identifies a large number of novel potential Sharpin interactors in addition to several known ones. These data suggest that Sharpin and LUBAC might regulate a larger number of biological processes than previously identified, such as endosomal trafficking, RNA processing, metabolism and cytoskeleton regulation. Importantly, using the Sharpin interactome, we have identified a novel role for Sharpin in lamellipodium formation. We demonstrate that Sharpin interacts with Arp2/3, a protein complex that catalyses actin filament branching. We have identified the Arp2/3-binding site in Sharpin and demonstrate using a specific Arp2/3-binding deficient mutant that the Sharpin–Arp2/3 interaction promotes lamellipodium formation in a LUBAC-independent fashion. This article has an associated First Person interview with the first author of the paper.

15 July 2024 in Development
Verified
Journal Article
Open access
CMCarla Mulas
Carla Mulas
MSMelanie Stammers
Melanie Stammers
SSSiiri I. Salomaa
Siiri I. Salomaa
CHConstanze Heinzen
Constanze Heinzen
DSDavid M. Suter
David M. Suter
KCKevin J. Chalut
Kevin J. Chalut
Naïve epiblast cells in the embryo and pluripotent stem cells in vitro undergo developmental progression to a formative state competent for lineage specification. During this transition, transcription factors and chromatin are rewired to encode new functional features. Here, we examine the role of mitogen-activated protein kinase (ERK1/2) signalling in pluripotent state transition. We show that a primary consequence of ERK activation in mouse embryonic stem cells is elimination of Nanog, which precipitates breakdown of the naïve state gene regulatory network. Variability in pERK dynamics results in heterogeneous loss of Nanog and metachronous state transition. Knockdown of Nanog allows exit without ERK activation. However, transition to formative pluripotency does not proceed and cells collapse to an indeterminate identity. This outcome is due to failure to maintain expression of the central pluripotency factor Oct4. Thus, during formative transition ERK signalling both dismantles the naïve state and preserves pluripotency. These results illustrate how a single signalling pathway can both initiate and secure transition between cell states.

20 July 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
CMCarla Mulas
Carla Mulas
MSMelanie Stammers
Melanie Stammers
SSSiiri I. Salomaa
Siiri I. Salomaa
CHConstanze Heinzen
Constanze Heinzen
DSDavid M. Suter
David M. Suter
KCKevin J. Chalut
Kevin J. Chalut
Naïve epiblast cells in the embryo and pluripotent stem cells in vitro undergo developmental progression to a formative state competent for lineage specification. During this transition, transcription factors and chromatin are rewired to encode new functional features. Here, we examine the role of mitogen-activated protein kinase (ERK1/2) signalling in pluripotent state transition. We show that a primary consequence of ERK activation in mouse embryonic stem cells is elimination of Nanog, precipitating breakdown of the naïve state gene regulatory network. Cell variability in pERK dynamics results in metachronous down-regulation of Nanog and naïve state exit. Knockdown of Nanog allows exit without ERK activation. However, transition to formative pluripotency does not proceed and cells collapse to an indeterminate identity. This failure is attributable to loss of expression of the central pluripotency factor Oct4. Thus, during formative transition ERK signalling both dismantles the naïve state and preserves pluripotency. These results illustrate that a single signalling pathway can both drive exit from a developmental state and safeguard progression to the successor state.

9 June 2026 in Development
Verified
Journal Article
Open access
ECElena Corujo-Simon
Elena Corujo-Simon
SSSiiri I. Salomaa
Siiri I. Salomaa
LBLawrence E. Bates
Lawrence E. Bates
AYAyaka Yanagida
Ayaka Yanagida
WMWilliam Mansfield
William Mansfield
KCKevin J. Chalut
Kevin J. Chalut
Stem cell-based models resembling murine blastocysts represent a useful system to investigate subsequent developmental processes. While existing cell lines derived from epiblast and trophectoderm can be aggregated to form ‘blastoids’, some previously tested in vitro cultured extraembryonic endoderm cells tended to progress to later stages of development, so integrated inefficiently into blastoids. We attempted to capture the precursor population for extraembryonic endoderm in vitro by reproducing the mechanical environment of the in vivo peri-implantation embryo as closely as possible. We investigated expression of candidate cell adhesion receptor integrins in the blastocyst inner cell mass, and from this information we assembled an extracellular matrix intended to support primitive endoderm growth by promoting signalling pathways responsible for specification of this lineage. In addition, inner cell mass cells from blastocysts were plated on soft or stiff substrates to investigate whether an appropriate mechano-environment could enhance their self-renewal as primitive endoderm in culture. We could expand nascent primitive endoderm cell lines over several passages, which provided a reproducible, albeit short-term, system sufficient to identify some essential requirements for early primitive endoderm expansion and function.